What is the Beta Drugs Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 1.02% of the total equity shares of Beta Drugs Ltd.

What is the Beta Drugs Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 6.23% of the total equity shares of Beta Drugs Ltd.

What is the Beta Drugs Ltd public shareholding?

Public shareholders hold 33.65% of the total equity shares of Beta Drugs Ltd as per the latest available data.

How has the Beta Drugs Ltd promoter holding changed?

The promoter holding in Beta Drugs Ltd changed from 59.10% to 59.10% during the latest reported period.

How has the Beta Drugs Ltd FII holding changed?

The FII holding in Beta Drugs Ltd changed from 2.95% to 1.02% during the latest reported period.

How has the Beta Drugs Ltd DII holding changed?

The DII holding in Beta Drugs Ltd changed from 6.01% to 6.23% during the latest reported period.

Who are the major shareholders of Beta Drugs Ltd?

The major shareholders of Beta Drugs Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Beta Drugs Ltd Shareholding Pattern: Promoters, FII, DII & Public

Beta Drugs Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk DrugsNSE

₹1,894.60

-76.40(-3.88%)

As on 23 Oct 2026 at 15:54

As of 23 Oct 2026 at 15:54, Beta Drugs Ltd is trading at ₹1,894.60. The 52-week range stands at ₹990.10–₹2,807.90, with a market cap of ₹2.10 thousand crore. At a P/E of 115.17 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.